Parallax Volatility Advisers
ATOS icon

Parallax Volatility Advisers’s Atossa Therapeutics ATOS Stock Holding History

Parallax Volatility Advisers’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14
Closed -$1K – 2542
2019
Q1 		$1K Hold
14
– – ﹤0.01% 2655
2018
Q4 		$0 Hold
14
– – ﹤0.01% 2896
2018
Q3 		$0 Hold
14
– – ﹤0.01% 2564
2018
Q2 		$0 Buy
+14
New +$752 ﹤0.01% 2100
2018
Q1 		– Sell
-14
Closed -$1K – 2256
2017
Q4 		$1K Buy
+14
New +$1.02K ﹤0.01% 3872

Other funds holding ATOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Parallax Volatility Advisers's ATOS Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of Atossa Therapeutics (ATOS) in Q2 2019, closing a stake of 14 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in ATOS in Q4 2017 and held it in 5 quarters. The position peaked at $1K in Q1 2019. 14 funds tracked by Wall St. Rank hold ATOS as of Q2 2019.

  • Parallax Volatility Advisers reported no remaining Atossa Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 14 Atossa Therapeutics shares in Q2 2019, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in Atossa Therapeutics in Q4 2017 and held it in 5 quarters.
  • Parallax Volatility Advisers's Atossa Therapeutics position peaked at $1K in Q1 2019.
  • 14 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.